Thrombotic microangiopathy after simultaneous pancreas - Kidney transplantation

Clinical Transplantation

Volumn 21, Issue 2, 2007, Pages 241-245

  Rangel, Érika B ^a   Gonzalez, Adriano M ^a   Linhares, Marcelo M ^a   Araújo, Sérgio R R ^a   Franco, Marcello F ^a   De Sá, João R ^a   Pestana, José O M ^a   Melaragno, Cláudio S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Pancreas kidney transplantation; Thrombotic microangiopathy

Indexed keywords

CREATININE; FRESH FROZEN PLASMA; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT FAILURE; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; STATISTICAL SIGNIFICANCE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADULT; CAPILLARIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TACROLIMUS; THROMBOSIS;

EID: 33947717831     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00633.x     Document Type: Article

References (23)

1. Trimarchi HM, Truong LD, Stephen B, Gonzalez JM, Suki WN. FK-506-associated thrombotic microangiopathy: Report of two cases and review of literature. Transplantation 1999: 67: 539.
2. Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Zand MS. De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 2003: 41: 471.
3. Lin CC, King KL, Chao YW, Yang AH, Chang C, Yang WC. Tacrolimus-associated hemolytic uremic syndrome: A case analysis. J Nephrol 2003: 16: 580.
4. Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after kidney transplantation in the United States. Am J Kidney Dis 2003: 42: 1058.
5. Bren A, Pajek J, Grego K et al. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy. Transplant Proc 2005: 37: 1889.
6. Candinas D, Keusch G, Schlumpf R, Burger HR, Weder W, Largiader F. Prognostic factors of hemolytic uremic syndrome in renal allografts. Transplant Proc 1993: 25: 1041.
7. Ruggenenti P, Lutz J, Remuzzi G. Pathogenesis and treatment of thrombotic microangiopathy. Kidney Int Suppl 1997: 58: S97.
8. Kaufman DB, Kaplan B, Kanwar YS, Abecassis M, Stuart FP. The successful use of tacrolimus (FK-506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. Transplantation 1995: 59: 1737.
9. Young BA, Marsh CL, Alpers CE, Davis CL. Cyclosporine thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis 1997: 28: 813.
10. Burke GW, Ciancio C, Cirocco R et al. Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with Tacrolimus: evidence of endothelin and cytokine involvement. Transplantation 1999: 68: 1336.
11. Chinnakotla S, Leone JP, Fidler ME, Hammeke MD, Tarantolo S. Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient. Transplantation 2000: 70: 550.
12. Evens AM, Kwann HC, Kaufman DB, Bennett CL. TTP/HUS in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology. Transplantation 2002: 74: 885.
13. Gutierrez de la Fuente C, Sola E, Alferez MJ et al. De novo hemolytic uremia síndrome in a kidney-pancreas recipient in the postoperative period. Nefrologia 2004: 24 (Suppl. 3): 3.
14. Jeejeebhoy FM, Zaltzman JS. Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant recipient. Transplantation 1998: 65: 1645.
15. Waiser J, Budde K, Rudolph B, Ortner MA, Neumayer HH. De novo hemolytic-uremic syndrome postrenal transplant after cytomegalovirus infection. Am J Kidney Dis 1999: 34: 556.
16. Artz MA, Steenbergen EJ, Hoistma AJ, Monnens LA, Wetzels JF. Renal transplantation in patients with hemolytic uremic syndrome: High rate of recurrence and increased incidence of acute rejections. Transplantation 2003: 76: 821.
17. Oyen O, Strom EH, Midtvedt K et al. Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome. Am J Transplant 2006: 6: 412.
18. Franco A, Hernandez D, Capdevilla L et al. De novo hemolytic-uremic síndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: Role of sirolimus. Transplant Proc 2003: 35: 1764.
19. Egidi MF, Cowan PA, Naseer A, Gaber AO. Conversion to sirolimus in solid organ transplantation: A single-center experience. Transplant Proc 2003: 35 (Suppl. 3): 131S.
20. Zarifian A, Meleg -Smith S, O'donovan R, Tesi RJ, Batuman V. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 1999: 55: 2457.
21. Langer RM, Van Buren CT, Katz SM, Kahan BD. De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination. Transplantation 2002: 73: 756.
22. Robson M, Côte I, Abbs I, Koffman G, Goldsmith D. Thrombotic micro-angiopathy with sirolimus-based immunosuppression: Potentiation of calcineurin-inhibitor-induced endothelial damage? Am J Transplant 2003: 3: 324.
23. Banerjee D, Kupin W, Roth D. Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin. J Nephrol 2003: 16: 733.